EyeKor, a developer of software for managing clinical trials of therapeutics for ocular diseases, has raised $600,000 in equity funding from five investors, according to a regulatory filing.

The Madison, WI-based company’s flagship product, called Excelsior, is a cloud-based software-as-a-service (SaaS) platform that helps researchers collect and interpret ophthalmic data. Excelsior, which in 2013received 510(k) clearance from the FDA, is specifically designed for image and data management in trials of drug candidates aimed at treating ocular diseases. Read the full story here.